In lung squamous cell carcinoma (LUSC), CD302 expression is significantly downregulated in tumor tissues and is positively correlated with angiogenesis, suggesting that it may influence LUSC progression by regulating tumor vascularization. Here, CD302 is linked to neoplasm.